Cardio Diagnostics begins using May 2023 investor presentation; no financial details disclosed

Cardio Diagnostics Holdings, Inc.

Senior management will use the presentation for meetings with investors effective May 16, 2023.
Presentation available on company website; specific content not included in filing excerpt.
No new financial guidance, operational updates, or material events announced in the 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.